Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Hypomethylation of tumor suppressor genes in odontogenic myxoma.

Moreira PR, Cardoso FP, Brito JA, Batista AC, Gomes CC, Gomez RS.

Braz Dent J. 2011;22(5):422-7.

2.

Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts.

Moreira PR, Guimarães MM, Guimarães AL, Diniz MG, Gomes CC, Brito JA, Gomez RS.

J Oral Pathol Med. 2009 Jan;38(1):99-103. doi: 10.1111/j.1600-0714.2008.00718.x.

PMID:
19192054
3.

Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.

Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J, Chen J, Zhang L, Wu M, Zhen S, Zhu J.

BMC Cancer. 2002 Nov 15;2:29. Epub 2002 Nov 15.

4.

Methylation frequencies of cell-cycle associated genes in epithelial odontogenic tumours.

Moreira PR, Guimarães MM, Gomes CC, Diniz MG, Brito JA, de Castro WH, Gomez RS.

Arch Oral Biol. 2009 Oct;54(10):893-7. doi: 10.1016/j.archoralbio.2009.07.006. Epub 2009 Aug 12.

PMID:
19679296
5.

Accumulation of DNA methylation is associated with tumor stage in gastric cancer.

Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, Nakayama H, Yasui W.

Cancer. 2006 Mar 15;106(6):1250-9.

6.

Methylation pattern of the IFN-gamma gene in human dental pulp.

Cardoso FP, Viana MB, Sobrinho AP, Diniz MG, Brito JA, Gomes CC, Moreira PR, Gomez RS.

J Endod. 2010 Apr;36(4):642-6. doi: 10.1016/j.joen.2009.12.017.

PMID:
20307737
7.

Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers.

Nguyen TT, Nguyen CT, Gonzales FA, Nichols PW, Yu MC, Jones PA.

Prostate. 2000 May 15;43(3):233-42.

PMID:
10797499
8.

Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.

Nakamura M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K, Konishi N.

Cancer Res. 2001 Sep 1;61(17):6335-9.

9.

Correlation of telomere length shortening with promoter methylation profile of p16/Rb and p53/p21 pathways in breast cancer.

Radpour R, Barekati Z, Haghighi MM, Kohler C, Asadollahi R, Torbati PM, Holzgreve W, Zhong XY.

Mod Pathol. 2010 May;23(5):763-72. doi: 10.1038/modpathol.2009.195. Epub 2010 Jan 15.

10.

INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.

Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.

Oncogene. 2001 Oct 25;20(48):7104-9.

11.

Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.

Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC.

Oncogene. 1998 Nov 26;17(21):2779-85.

12.

[Abnormal methylation of several tumor suppressor genes in sporadic breast cancer].

Zemliakova VV, Zhevlova AI, Strel'nikov VV, Liubchenko LN, Vishnevskaia IaV, Tret'iakova VA, Zaletaev DV, Nemtsova MV.

Mol Biol (Mosk). 2003 Jul-Aug;37(4):696-703. Russian.

PMID:
12942643
14.

Expression of senescence-related genes in human corneal endothelial cells.

Song Z, Wang Y, Xie L, Zang X, Yin H.

Mol Vis. 2008 Jan 29;14:161-70.

15.

Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.

Scott SA, Kimura T, Dong WF, Ichinohasama R, Bergen S, Kerviche A, Sheridan D, DeCoteau JF.

Leuk Res. 2004 Dec;28(12):1293-301.

PMID:
15475071
17.

Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.

Bisogna M, Calvano JE, Ho GH, Orlow I, Cordón-Cardó C, Borgen PI, Van Zee KJ.

Cancer Genet Cytogenet. 2001 Mar;125(2):131-8.

PMID:
11369056
18.

[The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis].

Chen M, Cui PG, Yao X, Cao YH, Gong JQ, Li AS, Chen ZQ.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Dec;24(6):674-6. Chinese.

PMID:
18067081
19.

Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.

Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC Jr.

Cancer. 2008 Apr 1;112(7):1489-502. doi: 10.1002/cncr.23323.

20.

Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.

Malekzadeh K, Sobti RC, Nikbakht M, Shekari M, Hosseini SA, Tamandani DK, Singh SK.

Cancer Invest. 2009 Jan;27(1):70-80. doi: 10.1080/07357900802172085.

PMID:
19160091

Supplemental Content

Support Center